Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 8;3(1):56.
doi: 10.1186/s42466-021-00156-7.

A neurologist's rhombencephalitis after comirnaty vaccination. A change of perspective

Alexander Walter  1 , Markus Kraemer  2   3
Affiliations

A neurologist's rhombencephalitis after comirnaty vaccination. A change of perspective

Alexander Walter et al. Neurol Res Pract. .

Abstract

Rhombencephalitis is an orphan disease of multiple causes that may manifest with facial palsy, limb ataxia and reduced consciousness. Up to now it is described after COVID-19 infection and in this (personal) case was found up to 8 weeks after Comirnaty vaccination. So far, we do not fully understand the pathophysiological characteristics of encephalitis associated with SARS-CoV-2. In rare cases, vaccination may cause an immunological reaction and delayed inflammation, the consequences of which we have not yet deciphered. Rhombencephalitis should be considered as a rare potential mRNA-associated vaccination side effect.

PubMed Disclaimer

Conflict of interest statement

AW declares that there is no conflict of interest. MK received honoraria for teaching activities from Roche Pharma and Chugai Pharma.

References

    1. LlorenteAyuso L, Torres Rubio P, Beijinho do Rosario RF, Giganto Arroyo ML, Sierra-Hidalgo F. Bickerstaff encephalitis after COVID-19. Journal of Neurology. 2021;268(6):2035–2037. doi: 10.1007/s00415-020-10201-1. - DOI - PMC - PubMed
    1. Maury A, Lyoubi A, Peiffer-Smadja N, de Broucker T, Meppiel E. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: a narrative review for clinicians. Rev Neurol (Paris) 2021;177(1–2):51–64. doi: 10.1016/j.neurol.2020.10.001. - DOI - PMC - PubMed
    1. Sriwastava S, Kataria S, Tandon M, Patel J, Patel R, Jowkar A, Daimee M, Bernitsas E, Jaiswal P, Lisak RP. Guillain barre syndrome and its variants as a manifestation of COVID-19: a systematic review of case reports and case series. Journal of the Neurological Sciences. 2021;420:117263. doi: 10.1016/j.jns.2020.117263. - DOI - PMC - PubMed
    1. Waheed S, Bayas A, Hindi F, Rizvi Z, Espinosa PS. Neurological complications of COVID-19: Guillain-Barre syndrome followIng Pfizer COVID-19 vaccine. Cureus. 2021;13(2):e13426. doi: 10.7759/cureus.13426. - DOI - PMC - PubMed
    1. Ye M, Ren Y, Lv T. Encephalitis as a clinical manifestation of COVID-19. Brain, Behavior, and Immunity. 2020;88:945–946. doi: 10.1016/j.bbi.2020.04.017. - DOI - PMC - PubMed

LinkOut - more resources